Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05767905 · ClinicalTrials.gov registry record · Phase 1
A Study to Understand the Effect of Tablet Formulation and Food on PF-06821497 in Healthy Adult Participants.
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT05767905 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 18 participants.
The verdict
NCT05767905, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to understand the effect of tablet formulation and presence of food on the study medicine PF-06821497 in healthy adult participants. The study is seeking for male and female participants who: * Are 18 years of age or more. * Are confirmed to be healthy after performing some medical and physical tests. * Weigh more than 50kgs of body weight and have a body mass index of 17 and a half kg per meter squared or more. The study consists of two parts. In each part of the study, the selected participants will take part in 3 study periods to receive 3 different treatments which are randomly assigned. There will also be a 5-day gap between each study period. This is done so that the medicine is passed out of the body before the start of next study period. Each treatment consists of a single dose of PF-06821497. The treatments differ by tablet formulation and/or whether the medicine is to be given with food or without food conditions. How the medicine is processed in the body will be studied after giving the medicines to the participants. This will be done by collecting blood samples after each administration. The results will be used to see the effect of tablet formulation and presence of food on the amount of PF-06821497 available in the blood of the participants. In each part, participants will be on the study up to 10 weeks, including the screening and follow-up periods.
Interventions
- DRUG PF-06821497 Treatment A
- DRUG PF-06821497 Treatment B
- DRUG PF-06821497 Treatment C
- DRUG PF-06821497 Treatment D
- DRUG PF-06821497 Treatment E
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2023-03-17 |
| Est. Completion | 2023-06-20 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05767905
The ClinicalTrials.gov registry entry for NCT05767905 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which PF-06821497 Treatment A is the first listed.
NCT05767905 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05767905 about?
NCT05767905 is a clinical study titled "A Study to Understand the Effect of Tablet Formulation and Food on PF-06821497 in Healthy Adult Participants.". The purpose of this study is to understand the effect of tablet formulation and presence of food on the study medicine PF-06821497 in healthy adult participants. The study is seeking for male and female participants who: * Are 18 years of age or more. * Are confirmed to be healthy after performing...
What is the current status of trial NCT05767905?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2023-03-17. Estimated completion is 2023-06-20.
What interventions are being tested in trial NCT05767905?
The interventions under investigation include: PF-06821497 Treatment A (DRUG), PF-06821497 Treatment B (DRUG), PF-06821497 Treatment C (DRUG), PF-06821497 Treatment D (DRUG), PF-06821497 Treatment E (DRUG).
Who is sponsoring clinical trial NCT05767905?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.